Tysabri FDA Meeting

By Johns Wu on Mar 07, 2006

The FDA will be holding a meeting today on Tysabri, the MS drug by ELN and BIIB. Trading in ELN is halted for the duration of this meeting, but be sure to keep an eye out for news because this news may drive these stocks in either direction. It probably would have been smart to buy straddles on ELN earlier.

Anyways, you can't go wrong with up-to the minute news or our in-house Tysabri analysis. So far the chatroom chatter is optimistic but you never know with this kind of stuff. I can't believe it's been over a year since I've been tracking ELN and the Tysabri mess.

This entry was posted on Tuesday, March 7th, 2006 at 4:07 am and is filed under Market News. You can skip to the end and leave a response. Pinging is currently not allowed.